Navigation Links
NCPA Statement in Response to President Bush's FY 2009 Budget Proposal
Date:2/4/2008

ALEXANDRIA, Va., Feb. 4 /PRNewswire-USNewswire/ --- President George W. Bush today submitted his budget proposal to Congress for fiscal year 2009. In response Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA) issued the following statement:

"President Bush's efforts to rein in government spending places a dangerous target on health care, and even more specifically the Medicare and Medicaid programs. While fiscal restraint is important and necessary, programs to support this nation's elderly and impoverished should be preserved, especially in the area of Medicaid generic prescription drug reimbursements.

"A patient's medical needs don't diminish just because their community pharmacy is threatened. In underserved rural and urban communities these patients lack options other than expensive emergency rooms and doctors' offices. The proposed savings are fictional. If adopted, the health care costs would actually rise because community pharmacies would not be there for their patients.

"We urge Congress to reject, as it has the last two years, this ill-advised gutting of Medicaid. We also hope the Democrat and Republican nominees for President will make sure to include policies in their health care proposals that do not hurt the small business, community pharmacy owners that so ably serve their patients on the front lines of America's health care system."

BACKGROUND:

For the third year in a row President Bush has sought to limit the Federal Upper Limit (FUL) pharmacies receive for participating in this program that provides economically disadvantaged Americans with their medication needs. The number has been reduced from 250% to 150% of Average Manufacturer price (AMP). This reduction significantly limits the ability of small business owners to serve their communities and patients. The Government Accountability Office has already calculated that a FUL reimbursement set at a maximum 250 percent of AMP will lead to reimbursements falling 36 percent below acquisition costs. Using a reduced 150 percent figure will likely cause reimbursement to fall more than 50 percent below the costs of the drugs themselves, without even considering the cost to dispense drugs.

In a recent report, Stephen W. Schondelmeyer, PharmD, PhD, director of the PRIME Institute at the University of Minnesota, provided dire warnings about the effects of the previously adopted Medicaid cuts that have been put on hold pending the results of litigation. Dr. Schondelmeyer indicated the retail pharmacy industry could see a loss of 10,000-12,000 pharmacies. The President's newest proposal only exacerbates the situation. While any small business owner will tell you that running a business based on these numbers is ruinous, the true victim of this policy will be the patient whose access to prescription drugs will be limited.

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
2. Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY09
3. NutraCea Files Universal Shelf Registration Statement
4. AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform
5. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
6. Statement of Robert K. Ross, M.D.
7. NCPA Statement on Wal-Marts Entry Into the Pharmacy Benefit Market
8. Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Statement by Bruce Bodaken on Senate Health Committee Action
10. AASM statement on use of sleep medications
11. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand marijuana ... the Icahn School of Medicine at Mount Sinai has found. The study was ... children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite of ...
(Date:12/7/2016)... ... December 07, 2016 , ... Wavelink, ... Device Remote Control through a new partnership with Splashtop Inc. This remote control ... mobile solutions to help businesses maximize their uptime and productivity. , Wavelink offers ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
(Date:12/7/2016)... Yorba Linda, Ca (PRWEB) , ... December 07, 2016 , ... ... to attain that funding is with useful, properly analyzed data. The team at Beckman ... generation to address the 'need for speed' and the need to operate in a ...
(Date:12/7/2016)... ... 2016 , ... A quote from Dr. Edward Hallowell, host of CRN International’s ... offer a rare glimpse into the mind of those people with ADHD. , Dr. ... author, has described people with ADHD as having “Ferrari engines for a brain, with ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) ... of reducing expression of Ki67, a biomarker of cell ... the Phase 2 trial presented during the official press ... (SABCS) evaluated abemaciclib, both alone or in combination with ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... REPORT OBJECTIVES The report ... intelligence on a market segment, based on geography. ... in the report. The primary objectives of this ... intelligence through detailed segmentation, 2) market size and ... developments, market situation, trends, 3) detailed analysis of ...
Breaking Medicine Technology: